Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy.
about
Toxic optic neuropathies: an updated reviewSafety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements.Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.Urologic medications and ophthalmologic side effects: a review.Chronic low dosing of phosphodiesterase type 5 inhibitor for erectile dysfunction.Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems.Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?Chronic sildenafil in men with diabetes and erectile dysfunction.Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction.Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunctionPDE5 inhibitors: considerations for preference and long-term adherence.Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten cases.Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage.Tadalafil significantly reduces ischemia reperfusion injury in skin island flaps.
P2860
Q27025010-24DA2FB6-D23F-4783-AD30-C27C5F904CCFQ33606588-D3285D0E-32D4-4AE7-ADFA-80E97A5F015DQ34446356-D7D39015-7EDB-4EF8-A01B-E0C13F08B5E2Q35768993-2CBED1FD-1492-41D3-8DBE-3FD74B6EE4E6Q35788323-B6B2EDBB-0D40-484D-AE10-7AFAC5864896Q36056990-8AB177BC-5FAE-4A12-89A2-0915E7447524Q36172099-0768E88D-5A74-47DF-BE5C-E2FF427DDE0DQ36500200-745558F6-3A16-49FD-89A1-D6792016FB3AQ36689825-4F0EE15C-947A-46A9-88B1-D772E8849D38Q36835843-35555B98-561D-4BCB-8183-2B158247E99AQ37182743-0E64F77A-2369-41B3-A47C-84C97CDDD7F2Q37427312-C95BD5F9-9C25-41DF-AF16-A310AD658B14Q38122721-8824F73B-19FD-45BF-921F-C52FB8966DDAQ41860984-E422A4B9-A523-47B5-886C-5A0668B84F3AQ42040524-B0F8BCC7-CE7C-4C3F-B82B-DB12BDBCD9FFQ42557220-E1C7A79A-94FC-4C75-9DC2-52006E92E8D0
P2860
Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Sildenafil citrate use and the ...... ior ischemic optic neuropathy.
@ast
Sildenafil citrate use and the ...... ior ischemic optic neuropathy.
@en
Sildenafil citrate use and the ...... ior ischemic optic neuropathy.
@nl
type
label
Sildenafil citrate use and the ...... ior ischemic optic neuropathy.
@ast
Sildenafil citrate use and the ...... ior ischemic optic neuropathy.
@en
Sildenafil citrate use and the ...... ior ischemic optic neuropathy.
@nl
prefLabel
Sildenafil citrate use and the ...... ior ischemic optic neuropathy.
@ast
Sildenafil citrate use and the ...... ior ischemic optic neuropathy.
@en
Sildenafil citrate use and the ...... ior ischemic optic neuropathy.
@nl
P2093
P2860
P1476
Sildenafil citrate use and the ...... rior ischemic optic neuropathy
@en
P2093
P2860
P304
P356
10.1111/J.1368-5031.2006.00904.X
P577
2006-04-01T00:00:00Z